These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
219 related items for PubMed ID: 25766588
1. Sorsby Fundus Dystrophy: Novel Mutations, Novel Phenotypic Characteristics, and Treatment Outcomes. Gliem M, Müller PL, Mangold E, Holz FG, Bolz HJ, Stöhr H, Weber BH, Charbel Issa P. Invest Ophthalmol Vis Sci; 2015 Apr; 56(4):2664-76. PubMed ID: 25766588 [Abstract] [Full Text] [Related]
2. Pattern dystrophy with high intrafamilial variability associated with Y141C mutation in the peripherin/RDS gene and successful treatment of subfoveal CNV related to multifocal pattern type with anti-VEGF (ranibizumab) intravitreal injections. Vaclavik V, Tran HV, Gaillard MC, Schorderet DF, Munier FL. Retina; 2012 Oct; 32(9):1942-9. PubMed ID: 22466463 [Abstract] [Full Text] [Related]
3. Evaluation of choroidal neovascularization with indocyanine green angiography in neovascular age-related macular degeneration subjects undergoing intravitreal bevacizumab therapy. Rush RB, Rush SW, Aragon AV, Ysasaga JE. Am J Ophthalmol; 2014 Aug; 158(2):337-44. PubMed ID: 24844972 [Abstract] [Full Text] [Related]
4. Reticular Pseudodrusen in Sorsby Fundus Dystrophy. Gliem M, Müller PL, Mangold E, Bolz HJ, Stöhr H, Weber BH, Holz FG, Charbel Issa P. Ophthalmology; 2015 Aug; 122(8):1555-62. PubMed ID: 26077580 [Abstract] [Full Text] [Related]
5. Long-term effectiveness of intravitreal bevacizumab for choroidal neovascularization secondary to angioid streaks in pseudoxanthoma elasticum. Finger RP, Charbel Issa P, Schmitz-Valckenberg S, Holz FG, Scholl HN. Retina; 2011 Aug; 31(7):1268-78. PubMed ID: 21386758 [Abstract] [Full Text] [Related]
6. Retinal dystrophy and subretinal drusenoid deposits in female choroideremia carriers. Murro V, Mucciolo DP, Passerini I, Palchetti S, Sodi A, Virgili G, Rizzo S. Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2099-2111. PubMed ID: 28752371 [Abstract] [Full Text] [Related]
7. Near-infrared autofluorescence in patients with idiopathic submacular choroidal neovascularization. Toju R, Iida T, Sekiryu T, Saito M, Maruko I, Kano M. Am J Ophthalmol; 2012 Feb; 153(2):314-9. PubMed ID: 21982958 [Abstract] [Full Text] [Related]
8. Clinical and biochemical effects of the E139K missense mutation in the TIMP3 gene, associated with Sorsby fundus dystrophy. Saihan Z, Li Z, Rice J, Rana NA, Ramsden S, Schlottmann PG, Jenkins SA, Blyth C, Black GC, McKie N, Webster AR. Mol Vis; 2009 Jun 15; 15():1218-30. PubMed ID: 19536307 [Abstract] [Full Text] [Related]
9. Intravitreal bevacizumab for the treatment of choroidal neovascularization secondary to angioid streaks: one year of follow-up. El Matri L, Kort F, Bouraoui R, Karim B, Chebil A, Chaker N. Acta Ophthalmol; 2011 Nov 15; 89(7):641-6. PubMed ID: 21155980 [Abstract] [Full Text] [Related]
10. Prognostic factors for visual outcome after intravitreal anti-VEGF injection for naive myopic choroidal neovascularization. Yoon JU, Kim YM, Lee SJ, Byun YJ, Koh HJ. Retina; 2012 May 15; 32(5):949-55. PubMed ID: 22534553 [Abstract] [Full Text] [Related]
11. Argon laser with and without anti-vascular endothelial growth factor therapy for extrafoveal polypoidal choroidal vasculopathy. Gemmy Cheung CM, Yeo I, Li X, Mathur R, Lee SY, Chan CM, Wong D, Wong TY. Am J Ophthalmol; 2013 Feb 15; 155(2):295-304.e1. PubMed ID: 23111181 [Abstract] [Full Text] [Related]
12. Intravitreal bevacizumab therapy on an as-per-needed basis in subfoveal choroidal neovascularization secondary to pathological myopia: 2-year outcomes of a prospective case series. Iacono P, Parodi MB, Papayannis A, Kontadakis S, Sheth S, Bandello F. Retina; 2011 Oct 15; 31(9):1841-7. PubMed ID: 21775926 [Abstract] [Full Text] [Related]
13. Sorsby fundus dystrophy - A review of pathology and disease mechanisms. Christensen DRG, Brown FE, Cree AJ, Ratnayaka JA, Lotery AJ. Exp Eye Res; 2017 Dec 15; 165():35-46. PubMed ID: 28847738 [Abstract] [Full Text] [Related]
14. [A new approach for studying the retinal and choroidal circulation]. Yoneya S. Nippon Ganka Gakkai Zasshi; 2004 Dec 15; 108(12):836-61; discussion 862. PubMed ID: 15656089 [Abstract] [Full Text] [Related]
15. Choroidal neovascularization associated with extensive macular atrophy with pseudodrusen-like appearance. Kamami-Levy C, Querques G, Rostaqui O, Blanco-Garavito R, Souied EH. J Fr Ophtalmol; 2014 Dec 15; 37(10):780-6. PubMed ID: 25278483 [Abstract] [Full Text] [Related]
16. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy. Lin RJ, Blumenkranz MS, Binkley J, Wu K, Vollrath D. Am J Ophthalmol; 2006 Nov 15; 142(5):839-48. PubMed ID: 16989765 [Abstract] [Full Text] [Related]
17. Choroidal thickness, vascular hyperpermeability, and complement factor H in age-related macular degeneration and polypoidal choroidal vasculopathy. Jirarattanasopa P, Ooto S, Nakata I, Tsujikawa A, Yamashiro K, Oishi A, Yoshimura N. Invest Ophthalmol Vis Sci; 2012 Jun 14; 53(7):3663-72. PubMed ID: 22570352 [Abstract] [Full Text] [Related]
18. Intravitreal bevacizumab for previously treated choroidal neovascularization from age-related macular degeneration. Goff MJ, Johnson RN, McDonald HR, Ai E, Jumper JM, Fu A. Retina; 2007 Jun 14; 27(4):432-8. PubMed ID: 17420694 [Abstract] [Full Text] [Related]
19. Intravitreal ranibizumab for the treatment of inflammatory choroidal neovascularization. Rouvas A, Petrou P, Douvali M, Ntouraki A, Vergados I, Georgalas I, Markomichelakis N. Retina; 2011 May 14; 31(5):871-9. PubMed ID: 21358461 [Abstract] [Full Text] [Related]